Market Place
Sourcing Support
All News #Library
Biotech
KSQ Therapeutics Doses 1st Patient in Ph 1/2 Study for KSQ-004EX
09 Apr 2025 //
GLOBENEWSWIRE
KSQ Therapeutics Appoints Kristen Hege, to its Board of Directors
05 Mar 2025 //
GLOBENEWSWIRE
KSQ Therapeutics Appoints John Lepore To Board
22 Oct 2024 //
GLOBENEWSWIRE
KSQ Therapeutics Appoints Anna Truppel-Hartmann As CMO
08 Oct 2024 //
GLOBENEWSWIRE
KSQ Therapeutics Gets FDA Clearance for KSQ-004EX IND Application
24 Sep 2024 //
GLOBENEWSWIRE
KSQ Therapeutics to Participate in Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
KSQ Doses First Patient With KSQ-001EX CRISPR-Engineered TILs
12 Jun 2024 //
GLOBENEWSWIRE
Japan`s Ono signs up for KSQ`s preclinical cancer programs
26 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.